What this means
The purpose of the study is to test the hypothesis of slowing the progression of White Matter Lesions (WML) by lowering blood pressure (BP) in patients with cognitive complaints and a moderate to high grade of WML on brain MRI.
A plain-English summary is on its way. Until then, this is the start of the registry's own summary.
- Status
- Recruiting
- Who can join
- Ages 60–88
- Where
- 2 sites
The science
- Registered title
- Blood Pressure Reduction to Limit the Evolution of Vascular Brain Lesions in Elderly Individuals
- Trial ID
- NCT02472028 ↗
- Phase
- PHASE 4
- Study type
- interventional
- Conditions
- Cerebrovascular Disorders
- What is tested
- blood pressure lowering algorithm, usual strategy
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Ages
- 60 Years to 88 Years
- Dates
- First posted Jun 15, 2015 · updated Oct 29, 2026
Registry summary
The purpose of the study is to test the hypothesis of slowing the progression of White Matter Lesions (WML) by lowering blood pressure (BP) in patients with cognitive complaints and a moderate to high grade of WML on brain MRI.
Sites (2)
- Memory for Research and Resources Center / Neuroscience pole, Bordeaux, Pellegrin Hospital Group, France
- Memory Resources Centre and South of Ile de France Search - Broca Hospital, Paris, France